Newson Research

Advancing understanding of female hormonal health through research and real-world evidence

Newson Research exists to advance understanding of female hormonal health across the lifespan through rigorous research, clinical insight and evidence-led investigation.
Its work explores the full-body impact of hormones, from physical and cognitive symptoms to mental health, long-term health and quality of life.

About Newson Research

Newson Research investigates the experiences of women, treatment outcomes and gaps in existing knowledge and care, helping to build a stronger evidence base for female hormonal health.

Drawing on clinical insight and real-world experience, its work seeks to challenge outdated thinking, improve understanding of the effects of hormones throughout the body and support more informed, individualised approaches to healthcare.

Through research and evidence-led investigation, Newson Research aims to contribute to better clinical understanding and ultimately improve health outcomes for women worldwide.

Growth Highlights

✔ 127 publications

✔ 164 million symptom logs

✔ #1 published women’s hormone research

PEAL’s Role

PEAL supported the platform by:

  • Supporting the development of research infrastructure and capabilities.

     

  • Helping connect clinical experience, data and research to generate meaningful real-world insight.

     

  • Supporting the translation of evidence into improved education, clinical understanding and patient care.

PEAL’s Investment Thesis

PEAL supports Newson Research as part of its commitment to advancing evidence-led, data-informed healthcare and addressing gaps in female hormonal health.
Combining rigorous research with real-world clinical insight, Newson Research strengthens the evidence base for better clinical practice and more individualised care.
Its work strengthens the wider Newson ecosystem and supports PEAL’s strategy of building high-impact, scalable healthcare businesses.

Looking to become an Investor?

$
img-1

PEAL Capital Partners Swiss AG is a registered member of Finanzombudsstelle Schweiz (FINOS)

Registered Office: Weidstrasse 9b
6300 Zug, Switzerland

Newsletter

Don’t miss the latest news

Copyright © 2025 PEAL CAPITAL GROUP All rights reserved.